Two experimental Ebola vaccines appear to be safe based on evaluation in more than 600 people in Liberia who participated in the first stage of the Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Phase 2/3 clinical trial, according to interim findings from an independent Data and Safety Monitoring Board review.
from The Medical News http://ift.tt/1bIeFdg
from The Medical News http://ift.tt/1bIeFdg
No comments:
Post a Comment